Informed consent, therapeutic misconception, and clinical trials for Alzheimer's disease

Int J Geriatr Psychiatry. 2020 May;35(5):430-435. doi: 10.1002/gps.5262. Epub 2020 Jan 26.

Authors

James M Wilkins^{1

2}, Brent P Forester^{1

2}

Affiliations

¹ Division of Geriatric Psychiatry, McLean Hospital, Belmont, MA.
² Department of Psychiatry, Harvard Medical School, Boston, MA.

No abstract available

Keywords: Alzheimer's disease; bioethics; clinical trials; informed consent; therapeutics.

Grants and funding

L30 AG060475/AG/NIA NIH HHS/United States